In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Two-way street: US-Ireland business relations are mutually beneficial
CFO Brendan Brennan comments in this article from the Irish Times about the importance of the American market for Irish companies.
-
Harmonising outsourcing to keep clinical trials on track
In this article in Applied Clinical Trials, Debbie Gilmore, Vice President, Strategic Alliance Management outlines how strategic partnerships and partnership-driven approaches to outsourcing can be used to navigate an increasingly complex clinical research landscape.
-
The role of digital therapeutics in central nervous system clinical trials
In this article, ICON's Louisa Steinberg and Maureen Glynn consider the role of digital therapeutics in the treatment of central nervous system conditions and how they can be used to improve clinical trials.
-
Confidently compliant? Considerations for industry players to meet the new EMA guideline
Vesta Marciulioniene, Director, Global Regulatory Clinical Services and Jo Hulbert, Executive Director, Global Regulatory Clinical Services provide an overview of the EMA’s new framework on computerised systems and electronic data in clinical trials in this article from XTalks Clinical Edge.
-
Dublin-headquartered Icon plc reports double-digit third quarter profit growth
This article from the Business Post reports that Icon plc has reported double-digit profit growth for the third quarter of 2023.
-
ICON releases Q3 financial results
CFO Brendan Brennan is interviewed by Emmet Oliver on Newstalk’s Breakfast Business on ICON’s Q3 2023 financial results.
-
The Pharma Letter Podcast: CRO sector surges in bio revolution
This episode of The Pharma Letter Podcast features an interview with ICON’s Chief Commercial Officer, George McMillan, who outlines how ICON is growing in size to take advantage of increasing demand for its services.
-
Report from Global Site Solutions Summit October 2023
In this article in Contract Pharma, April Coburn, Associate Director, Therapeutics – Global Site Partnerships provides an overview of the discussion on different site operation levels from the recent Global Site Solutions Summit.
-
Outsourcing Model Usage and its Relationship to Clinical Trial Performance
This article provides details on recent ICON plc collaboration with Tufts CSDD on a pilot study that seeks to validate new and more granular outsourcing model classifications in differentiating performance across custom contract-service approaches.
-
Centred on decentralised trials: Q&A with Harpreet Gill
In this article on Pharmaceutical Executive’s website, Harpreet Gill discusses how DCTs can transform clinical trials and improve the patient experience.
